These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3303448)

  • 1. Interspecies differences in peroxisomes and peroxisome proliferation.
    Rodricks JV; Turnbull D
    Toxicol Ind Health; 1987 Jun; 3(2):197-212. PubMed ID: 3303448
    [No Abstract]   [Full Text] [Related]  

  • 2. Species differences in di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation.
    Lake BG; Gray TJ; Foster JR; Stubberfield CR; Gangolli SD
    Dev Toxicol Environ Sci; 1983; 11():595-8. PubMed ID: 6677511
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic and peroxisome proliferation studies with di(2-ethylhexyl)phthalate in rats and monkeys.
    Short RD; Robinson EC; Lington AW; Chin AE
    Toxicol Ind Health; 1987 Jun; 3(2):185-95. PubMed ID: 3617067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS; Cattley RC; Conway JG; Popp JA
    Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome induction studies on di(2-ethylhexyl)terephthalate.
    Topping DC; Ford GP; Evans JG; Lake BG; O'Donoghue JL; Lockhart HB
    Toxicol Ind Health; 1987 Jun; 3(2):63-78. PubMed ID: 3617070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in hepatic peroxisome proliferation.
    Lake BG; Gray TJ
    Biochem Soc Trans; 1985 Oct; 13(5):859-61. PubMed ID: 4065421
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolism of mono-(2-ethylhexyl) phthalate (MEHP) and liver peroxisome proliferation in the hamster.
    Lhuguenot JC; Mitchell AM; Elcombe CR
    Toxicol Ind Health; 1988 Dec; 4(4):431-41. PubMed ID: 3188042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of rodent liver carcinogenesis.
    Michalopoulos GK; Eckl PM; Cruise JL; Novicki DL; Jirtle RL
    Toxicol Ind Health; 1987 Jun; 3(2):119-28. PubMed ID: 3303445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate.
    Conway JG; Cattley RC; Popp JA; Butterworth BE
    Drug Metab Rev; 1989; 21(1):65-102. PubMed ID: 2696637
    [No Abstract]   [Full Text] [Related]  

  • 10. Xenobiotic-induced peroxisome proliferation: role of tissue specificity and species differences in response in the evaluation of the implications for human health.
    Reddy JK; Rao MS
    Arch Toxicol Suppl; 1987; 10():43-53. PubMed ID: 3555419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical study of the ultrastructure of peroxisomes and the effects of peroxisome proliferators.
    Usuda N; Nakazawa A; Terasawa M; Reddy JK; Nagata T
    Ann N Y Acad Sci; 1996 Dec; 804():297-309. PubMed ID: 8993552
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
    Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
    Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
    Reddy JK; Lalwai ND
    Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of peroxisome induction studies on tri(2-ethylhexyl)trimellitate and 2-ethylhexanol.
    Hodgson JR
    Toxicol Ind Health; 1987 Jun; 3(2):49-61. PubMed ID: 3617069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic toxicity of Di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia.
    Kurata Y; Kidachi F; Yokoyama M; Toyota N; Tsuchitani M; Katoh M
    Toxicol Sci; 1998 Mar; 42(1):49-56. PubMed ID: 9538047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk.
    Huber WW; Grasl-Kraupp B; Schulte-Hermann R
    Crit Rev Toxicol; 1996 Jun; 26(4):365-481. PubMed ID: 8817083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression.
    Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA
    Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive potential of omega-3 fatty acids with clofibrate or DEHP on hepatic peroxisome proliferation in male Wistar rats.
    Wysynski AM; Baldwin LA; Leonard DA; Calabrese EJ
    Hum Exp Toxicol; 1993 Jul; 12(4):337-40. PubMed ID: 8104013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure activity requirements for phthalate ester-induced peroxisome proliferation in primary cultures of rat hepatocytes.
    Gray TJ; Lake BG; Beamand JA; Purchase R; Gangolli SD
    Dev Toxicol Environ Sci; 1983; 11():591-4. PubMed ID: 6677510
    [No Abstract]   [Full Text] [Related]  

  • 20. Phthalate esters, cystic kidney disease in animals and possible effects on human health: a review.
    Woodward KN
    Hum Exp Toxicol; 1990 Nov; 9(6):397-401. PubMed ID: 2271232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.